These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34660129)

  • 21. Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis.
    Omar D; Chen Y; Cong Y; Dong L
    Rheumatology (Oxford); 2020 Apr; 59(4):718-726. PubMed ID: 31511884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG4-related pachymeningitis masquerading as foramen magnum meningioma: illustrative case.
    Suisa H; Soustiel JF; Grober Y
    J Neurosurg Case Lessons; 2021 Dec; 2(23):CASE21398. PubMed ID: 36061082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Case Series of Patients with Isolated IgG4-related Hypophysitis Treated with Rituximab.
    Boharoon H; Tomlinson J; Limback-Stanic C; Gontsorova A; Martin N; Hatfield E; Meeran K; Nair R; Mendoza N; Levy J; McAdoo S; Pusey C; Wernig F
    J Endocr Soc; 2020 Jun; 4(6):bvaa048. PubMed ID: 32537540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retroperitoneal fibrosis. Steroid treatment response seems to depend on its association to IgG4 related disease.
    Soriano Rios A; Paredes H; Hernández-Calleros J; Uscanga-Domínguez L; Peláez-Luna M
    Med Hypotheses; 2019 Jan; 122():120-123. PubMed ID: 30593393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease.
    Majumder S; Mohapatra S; Lennon RJ; Piovezani Ramos G; Postier N; Gleeson FC; Levy MJ; Pearson RK; Petersen BT; Vege SS; Chari ST; Topazian MD; Witzig TE
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1947-1953. PubMed ID: 29526692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients.
    Campochiaro C; Ramirez GA; Bozzolo EP; Lanzillotta M; Berti A; Baldissera E; Dagna L; Praderio L; Scotti R; Tresoldi M; Roveri L; Mariani A; Balzano G; Castoldi R; Doglioni C; Sabbadini MG; Della-Torre E
    Scand J Rheumatol; 2016; 45(2):135-45. PubMed ID: 26398142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of possible immunoglobulin G4-related disease (IgG4-RD) with retroperitoneal fibrosis and central diabetes insipidus due to infundibulohypophysitis].
    Tanaka J; Arai A; Hayashi S; Sakagami Y; Araki K; Kakiuchi S; Nomura T; Kuwamura K; Kohmura E
    No Shinkei Geka; 2014 Jun; 42(6):561-6. PubMed ID: 24920744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab for IgG4-related disease: a prospective, open-label trial.
    Carruthers MN; Topazian MD; Khosroshahi A; Witzig TE; Wallace ZS; Hart PA; Deshpande V; Smyrk TC; Chari S; Stone JH
    Ann Rheum Dis; 2015 Jun; 74(6):1171-7. PubMed ID: 25667206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab.
    Backhus J; Neumann C; Perkhofer L; Schulte LA; Mayer B; Seufferlein T; Müller M; Kleger A
    J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33807051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial.
    Wang Y; Zhao Z; Gao D; Wang H; Liao S; Dong C; Luo G; Ji X; Li Y; Wang X; Zhao Y; Li K; Zhang J; Jin J; Zhang Y; Zhu J; Zhang J; Huang F
    Semin Arthritis Rheum; 2020 Dec; 50(6):1513-1520. PubMed ID: 32113839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An enigmatic case of IgG4-related nephropathy and an updated review of the literature.
    Spatola L; Ravera F; Sghirlanzoni MC; Verdesca S; Menegotto A; Querques M; Camozzi ML; Colombo V; Minetti EE
    Clin Exp Med; 2021 Aug; 21(3):493-500. PubMed ID: 33683496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin G4-related Disease: An Overview.
    Kawa S
    JMA J; 2019 Mar; 2(1):11-27. PubMed ID: 33681509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probable Immunoglobulin Subtype-G4-Related Disease in the Head and Neck from Foreign Body Injection: A Case Report.
    Highstein MJ; Mallen J; Tham T; Brennan T; Boubour A; Opher E; Wolf V; Singh P; Costantino P
    J Neurol Surg Rep; 2015 Nov; 76(2):e265-9. PubMed ID: 26623239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectives.
    Lanzillotta M; Stone JH; Della-Torre E
    Mod Rheumatol; 2023 Mar; 33(2):258-265. PubMed ID: 35983918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of tubulointerstitial nephritis in immunoglobulin G4-related disease with rituximab: A case report.
    Eroglu E; Sipahioglu MH; Senel S; Ertas SK; Savas S; Ozturk F; Kocyigit I; Tokgoz B; Oymak O
    World J Clin Cases; 2019 Aug; 7(16):2309-2315. PubMed ID: 31531324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary artery disease concomitant with immunoglobulin G4-related disease: a case report and literature review.
    Okuyama T; Tanaka TD; Nagoshi T; Yoshimura M
    Eur Heart J Case Rep; 2019 Mar; 3(1):ytz013. PubMed ID: 31020256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of tofacitinib monotherapy for patients with IgG4-RD or idiopathic retroperitoneal fibrosis.
    Cao X; Li S; Wan J; Yu Z; Dong G; Zhou W
    Clin Exp Rheumatol; 2024 Mar; ():. PubMed ID: 38530663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.
    Ebbo M; Grados A; Samson M; Groh M; Loundou A; Rigolet A; Terrier B; Guillaud C; Carra-Dallière C; Renou F; Pozdzik A; Labauge P; Palat S; Berthelot JM; Pennaforte JL; Wynckel A; Lebas C; Le Gouellec N; Quémeneur T; Dahan K; Carbonnel F; Leroux G; Perlat A; Mathian A; Cacoub P; Hachulla E; Costedoat-Chalumeau N; Harlé JR; Schleinitz N
    PLoS One; 2017; 12(9):e0183844. PubMed ID: 28915275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
    Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
    J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease.
    Hara A; Watanabe T; Minaga K; Yoshikawa T; Kamata K; Kudo M
    World J Gastroenterol; 2021 May; 27(19):2257-2269. PubMed ID: 34040320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.